Norris Perne & French LLP/Mi / MRK
Norris Perne & French LLP/Mi’s Merck & Co Inc Position
Does Norris Perne & French LLP/Mi own Merck & Co Inc (MRK)? Yes — 173.9K shares worth $21M (+1.40% of its 13F portfolio) as of Q1 2026, down from 252.2K shares the prior filed quarter.
Position Value
$21M
Q1 2026
Shares
173.9K
% of Portfolio
+1.40%
Quarters Held
30
currently held
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 173.9K | $21M | +1.40% |
| Q4 2025 | 252.2K | $27M | +1.75% |
| Q3 2025 | 223.5K | $19M | +1.30% |
| Q2 2025 | 260.3K | $21M | +1.44% |
| Q1 2025 | 258.1K | $23M | +1.74% |
| Q4 2024 | 255.8K | $25M | +1.83% |
| Q3 2024 | 254.9K | $29M | +1.98% |
| Q2 2024 | 203.0K | $25M | +1.82% |
| Q1 2024 | 203.7K | $27M | +1.93% |
| Q4 2023 | 203.2K | $22M | +1.71% |
| Q3 2023 | 173.7K | $18M | +1.56% |
| Q2 2023 | 171.9K | $20M | +1.67% |
| Q1 2023 | 170.5K | $18M | +1.66% |
| Q4 2022 | 171.8K | $19M | +1.88% |
| Q3 2022 | 171.3K | $15M | +1.53% |
| Q2 2022 | 241.8K | $22M | +2.12% |
| Q1 2022 | 242.0K | $20M | +1.60% |
| Q4 2021 | 243.5K | $19M | +1.45% |
| Q3 2021 | 324.5K | $24M | +2.09% |
| Q2 2021 | 315.7K | $25M | +2.12% |
| Q1 2021 | 267.8K | $21M | +1.91% |
| Q4 2020 | 272.8K | $22M | +2.10% |
| Q3 2020 | 246.8K | $20M | +2.22% |
| Q2 2020 | 199.1K | $15M | +1.87% |
| Q1 2020 | 191.5K | $15M | +2.21% |
| Q4 2019 | 160.0K | $15M | +1.74% |
| Q3 2019 | 159.8K | $13M | +1.68% |
| Q2 2019 | 159.6K | $13M | +1.69% |
| Q1 2019 | 159.5K | $13M | +1.75% |
| Q4 2018 | 154.8K | $12M | +1.85% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norris Perne & French LLP/Mi’s full portfolio or all institutional holders of MRK.